Haemophagocytic Lymphohistiocytosis Following Severe Erysipelas with EBV Reactivation
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0822Keywords:
macrophage activation syndrome, cellulitis, Epstein-Barr virusDownloads
References
Khare N, Jinkala SR, Kanungo S. Performance of HScore in reactive hemophagocytic lymphohistiocytosis. Indian J Hematol Blood Transfus 2021; 37: 256–263. DOI: https://doi.org/10.1007/s12288-020-01342-4
Chang CC, Hsiao PJ, Chiu CC, Chen YC, Lin SH, Wu CC, et al. Catastrophic hemophagocytic lymphohistiocytosis in a young man with nephrotic syndrome. Clin Chim Acta 2015; 439: 168–171. DOI: https://doi.org/10.1016/j.cca.2014.10.025
Boggio F, Lora V, Cota C, Pereira A, Müllegger R, Prieto-Torres L, et al. Cutaneous hemophagocytosis: clinicopathologic features of 21 cases. J Am Acad Dermatol 2018; 78: 377–382. DOI: https://doi.org/10.1016/j.jaad.2017.08.041
Kuntz N, Grovas LJ, Tang R, Armanyous Y, Hoerig C, Torno L, et al. Cutaneous manifestations in an infant with hemophagocytic lymphohistiocytosis: case report. J Pediatr Hematol Oncol Nurs 2025; 42: 202–209. DOI: https://doi.org/10.1177/27527530251356970
Hall AD, Salibindla D, Dubocq-Cabrera L, Hunt M, Rotert LM, Johnson RS, et al. Progressive disseminated histoplasmosis with dermatomyositis and macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Am J Trop Med Hyg 2025; 113: 773–780. DOI: https://doi.org/10.4269/ajtmh.24-0802
Baba M, Fenech M, Saeed MU, McCormick A, Jawad M. A rare case of orbital inflammation complicated by hemophagocytic lymphohistiocytosis. Orbit 2024; 43: 751–754. DOI: https://doi.org/10.1080/01676830.2023.2274868
Puing AG, Raghavan SS, Aleshin MA, Ho DY. Hemophagocytic lymphohistiocytosis secondary to progressive disseminated histoplasmosis presenting as cellulitis. Med Mycol Case Rep 2021; 33: 18–20. DOI: https://doi.org/10.1016/j.mmcr.2021.06.002
Tzeng HE, Teng CL, Yang Y, Young JH, Chou G. Occult subcutaneous panniculitis-like T-cell lymphoma with initial presentations of cellulitis-like skin lesion and fulminant hemophagocytosis. J Formos Med Assoc 2007; 106: S55–9. DOI: https://doi.org/10.1016/S0929-6646(09)60354-5
Liu D, Pei X, Zhang X, Xu L, Wang Y, Yan C, et al. Clinical manifestations and outcomes of EBV-related secondary hemophagocytic lymphohistiocytosis. Ann Hematol 2025; 104: 5605–5613. DOI: https://doi.org/10.1007/s00277-025-06677-4
La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019; 133: 2465–2477. DOI: https://doi.org/10.1182/blood.2018894618
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
